4.4 Review

Integrating Interleukin-6 into depression diagnosis and treatment

Journal

NEUROBIOLOGY OF STRESS
Volume 4, Issue -, Pages 15-22

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ynstr.2016.03.003

Keywords

-

Categories

Funding

  1. Brain and behavior research foundation NARSAD young investigator award
  2. National Center for Complementary and Integrative Health (NCCIH) [P50 AT008661-01]
  3. Office of Dietary Supplements (ODS)
  4. [R01MH104559]
  5. [R01MH090264]
  6. [R21MH099562]

Ask authors/readers for more resources

There is growing evidence of a relationship between inflammation and psychiatric illness. In particular, the cytokine Interleukin-6 (IL-6) has been linked to stress-related disorders such as depression and anxiety. Here we discuss evidence from preclinical and clinical studies examining the role of IL-6 in mood disorders. We focus on the functional role of peripheral and central release of IL-6 on the development of stress susceptibility and depression-associated behavior. By examining the contribution of both peripheral and central IL-6 to manifestations of stress-related symptomatology, we hope to broaden the way the field thinks about diagnosing and treating mood disorders. (C) 2016 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available